Combination Therapy With Proteasome Inhibitors and TLR Agonists Enhances Tumour Cell Death and IL-1β Production

Cell Death and Disease - United Kingdom
doi 10.1038/s41419-017-0194-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Neutrophil Extracellular Traps Induce IL-1β Production by Macrophages in Combination With Lipopolysaccharide

International Journal of Molecular Medicine
MedicineGenetics
2017English

Differential Production of IL-23 and IL-12 by Myeloid-Derived Dendritic Cells in Response to TLR Agonists

Journal of Immunology
AllergyImmunology
2008English

Proteasome Inhibitors in Cancer Therapy

2004English

Serine Metabolism Supports Macrophage IL-1β Production

Cell Metabolism
Cell BiologyMolecular BiologyPhysiology
2019English

Association of IL-1β, IL-1RN, and ESR1 Genes Polymorphism With Risk of Infection and Response to Sofosbuvir Plus Daclatasvir Combination Therapy in Hepatitis C Virus Genotype-4 Patients

IUBMB Life
BiochemistryGeneticsClinical BiochemistryCell BiologyMolecular Biology
2018English

Combination Therapy With BRAF and MEK Inhibitors for Melanoma: Latest Evidence and Place in Therapy

Therapeutic Advances in Medical Oncology
Oncology
2015English

The Efficacy Versus Toxicity Profile of Combination Virotherapy and TLR Immunotherapy Highlights the Danger of Administering TLR Agonists to Oncolytic Virus-Treated Mice

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

Mammalian Target of Rapamycin (mTOR) and the Proteasome Attenuates IL-1β Expression in Primary Mouse Cardiac Fibroblasts

Frontiers in Immunology
AllergyImmunology
2019English

IL-21 in Synergy With IL-15 or IL-18 Enhances IFN- Production in Human NK and T Cells

Journal of Immunology
AllergyImmunology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy